Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Integrum ABFRA:6Y1 -2.62%57 Days Inventory is 303.43 as of Apr. 2026, which is 24% below its 10-year median of 396.95. GuruFocus rates FRA:6Y1 with a GF Score™ of 57/100 and a GF Value™ of €1.54 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Integrum AB ranks worse than 85.37% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Integrum AB's Average Total Inventories for the
three
months ended in Apr. 2026 was €2.96 Mil. Integrum AB's Cost of Goods Sold for the
three
months ended in Apr. 2026 was €0.89 Mil.
Hence, Integrum AB's Days Inventory for the
three
months ended in Apr. 2026 was 303.43.
The historical rank and industry rank for Integrum AB's Days Inventory or its related term are showing as below:
FRA:6Y1'
s Days Inventory Range Over the Past 10 Years
Min: 305.93 Med: 396.95 Max: 616.66
Current: 392.57
During the past 12 years, Integrum AB's highest Days Inventory was 616.66. The lowest was 305.93. And the median was 396.95.
FRA:6Y1's Days Inventory is ranked worse than 85.37% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs FRA:6Y1: 392.57
Integrum AB's Days Inventory
increased
from Apr. 2025 (288.36) to Apr. 2026 (303.43).
It might indicate that Integrum AB's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Integrum AB's Inventory Turnover for the
three
months ended in Apr. 2026 was 0.30.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Integrum AB's Inventory-to-Revenue for the
three
months ended in Apr. 2026 was 1.28.
Integrum AB (FRA:6Y1) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Integrum AB's Inventory Turnover for the
three
months ended in Apr. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Integrum AB's Inventory to Revenue for the
three
months ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Integrum AB Days Inventory Related Terms
Integrum AB Days Inventory Historical Data
* Premium members only.
The historical data trend for Integrum AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:6Y1 vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Integrum AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrum AB Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Integrum AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integrum AB (FRA:6Y1) has a Days Inventory of 303.43 as of Apr. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Integrum AB and its competitors. This is 24% below median its historical median of 396.95. Over the past decade, Integrum AB's Days Inventory has ranged from 305.93 to 616.66. According to the industry distribution chart, Integrum AB ranks #671 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 85.4%.
Is Integrum AB's Days Inventory too high?
Integrum AB's current Days Inventory of 303.43 is 24% below median its 10-year median of 396.95. Over the past 10 years, this metric has ranged from a low of 305.93 to a high of 616.66. The Medical Devices & Instruments industry median Days Inventory is 179.60. Integrum AB's value of 303.43 is 68.9% above this industry median. Based on the distribution chart, Integrum AB ranks #671 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Integrum AB has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrum AB's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Integrum AB ranks #671 out of 786 companies for Days Inventory. This places Integrum AB in the lower half of its industry. The industry median Days Inventory is 179.60. Integrum AB's value of 303.43 is 68.9% above this benchmark. Historically, Integrum AB's own Days Inventory has ranged from 305.93 to 616.66 over the past decade. While the company's 10-year median is 396.95 vs. the industry median of 179.60, Integrum AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integrum AB's current Days Inventory of 303.43 is 68.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Integrum AB and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integrum AB's current Days Inventory is 303.43, which is 24% below median its own 10-year median of 396.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrum AB stock overvalued right now?
Based on GuruFocus' analysis, Integrum AB (FRA:6Y1) is currently considered Possible Value Trap. The stock's GF Value™ is €1.54, compared to a current price of €0.67 — trading 56.5% below its estimated fair value. The current Days Inventory is 303.43, which is 24% below median its 10-year median of 396.95 and 68.9% above the Medical Devices & Instruments industry median of 179.60. Integrum AB's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Integrum AB (FRA:6Y1), the current Days Inventory is 303.43 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integrum AB (FRA:6Y1) Overvalued in 2026?
Based on GuruFocus' analysis, Integrum AB stock appears to be undervalued.
The current stock price of €0.67 is trading 56.5% below its estimated GF Value™ of €1.54.
GuruFocus considers Integrum AB to be Possible Value Trap.
Key valuation signals for FRA:6Y1:
Days Inventory: 303.43 (24% below median its 10-year median of 396.95)
GF Value™: €1.54 vs. price of €0.67 (56.5% below fair value)
Industry Position: 68.9% above the Medical Devices & Instruments median (#671 of 786)
No single metric tells the full story. See the FRA:6Y1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
57GF Score
Get the complete analysis for FRA:6Y1
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6Y1 has been successfully added to your 
